Hain Celestial Group Inc (HAIN) Stock Analysis and Metrics

Hain Celestial

NASDAQ: HAIN

$0.54 ▼ -0.01 (-0.97%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap48.74 Mn

P/E-0.70

P/S0.03

Div. Yield0.00

ROIC (Qtr)-0.01

Total Debt (Qtr)549.50 Mn

Revenue Growth (1y) (Qtr)-13.32

Add ratio to table…

About

The Hain Celestial Group, Inc. is a leading global health and wellness company that inspires healthier living for people, communities and the planet through better for you brands. Founded in 1993 and headquartered in Hoboken, New Jersey, the company markets and sells its products in more than seventy countries worldwide. Its portfolio spans snacks, baby and kids foods, beverages, meal preparation items and personal care products. Well known brands include Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's jelly, Earth's Best Organic, Ella's Kitchen baby and kid foods, Celestial Seasonings teas, Joya and Natumi plant based beverages, The Greek Gods yogurt, Cully & Sully, Yorkshire Provender, New Covent Garden and Imagine soups among others. The Hain Celestial Group, Inc. focuses on delivering nutrition and well being that positively impacts today and tomorrow through purpose driven brand building.

The company generates revenue primarily by selling its branded food and beverage products to a diverse range of retail and food service channels. Sales are made through supermarkets, natural food stores, mass market retailers, club stores, specialty and natural food distributors, ecommerce platforms and away from home outlets such as drug stores, convenience stores and food service operators. Revenue also stems from personal care items sold via similar distribution networks. A portion of the company's sales comes from products manufactured in its own facilities while the remainder is produced by co packers under strict quality and safety standards. The Hain Celestial Group, Inc. manages pricing, promotional activity and product mix to drive top line growth and improve profitability across its geographic markets.

The Hain Celestial Group, Inc. operates in a highly competitive consumer packaged goods environment where it faces both large conventional packaged goods companies and natural and organic focused rivals. Major competitors in the food and beverage space include Campbell Soup Company, Conagra Brands, Danone S. A., General Mills, The Hershey Company, The J. M. Smucker Company, Kellanova, Mondelez International, Nestle S. A. and PepsiCo Inc. In the personal care category the company competes with The Clorox Company, Colgate-Palmolive Company, Johnson & Johnson, The Procter & Gamble Company and S. C. Johnson & Son Inc. The Hain Celestial Group, Inc. differentiates itself through a broad portfolio of better for you brands, ongoing innovation and renovation of existing products, a strong private label capability and a commitment to sustainable manufacturing and sourcing practices. Its ability to leverage direct sales teams, brokers and distributors enables broad market reach while its focus on nutrition, taste and clean label attributes helps maintain consumer loyalty in a crowded marketplace.

The company serves a wide array of customers that include supermarket chains, natural food retailers, mass market merchants, club stores, specialty food distributors, ecommerce retailers and food service providers. In North America the customer base consists principally of supermarkets, natural food stores, mass market outlets, club stores, specialty and natural food distributors, ecommerce retailers and away from home channels such as drug stores, convenience stores and food service operators. In Canada the customer base includes grocery supermarkets, club stores, mass merchandisers, natural food distributors, drug store chains, personal care distributors and food service distributors. In the United Kingdom and Ireland the company sells to retailers, convenience stores, food service providers, business to business partners, natural food and ethnic specialty distributors, club stores, ecommerce retailers and wholesalers. Across Western Europe, the Middle East and Africa its products are distributed through grocery stores, organic food stores and local distributors. Walmart Inc. and its affiliates represented approximately eighteen percent of consolidated net sales in the fiscal year ended June 30 2025 and no other single customer accounted for ten percent or more of net sales in any of the past three fiscal years.

Investment Thesis

▲ Bull case

The company’s innovation pipeline is a powerful but underappreciated driver of future growth, with more than 12% of net sales now coming from SKUs launched or relaunched within the last three years, up 2.5 points year‑over‑year. This acceleration is supported by concrete product rollouts such as Celestial Seasonings’ wellness tea expansion into gut health and throat support, Earth’s Best Big Kids finger foods, and Greek Gods’ high‑protein single‑serve yogurt, each targeting fast‑growing consumer trends. Management has explicitly linked these innovations to broader distribution gains, repeat purchase behavior, and the ability to command premium pricing, which should translate into sustainable top‑line expansion. The innovation effort is further reinforced by increased marketing effectiveness through digital and social channels, ensuring that new products achieve shelf visibility and consumer trial. As the pipeline continues to mature, the flow‑through benefits to gross margin and operating leverage are likely to exceed current market expectations. Consequently, the stock may be undervaluing the earnings upside from a revitalized product portfolio that can drive both volume recovery and margin expansion.
Debt reduction and balance sheet strengthening provide a tangible catalyst that the market appears to be overlooking. The completed North America Snacks divestiture generated $155 million in debt reduction, cutting net debt to $505 million and improving liquidity to $196 million under the revolver, while leverage stands at a comfortable 4.3x versus a covenant of 5.5x. This deleveraging not only reduces interest expense pressure but also creates flexibility for future strategic moves, such as additional asset sales or reinvestment into high‑growth categories. Management’s commitment to prioritizing net debt reduction over time, coupled with a hedged rate exposure of over 70% at a fixed 7.1%, mitigates refinancing risk ahead of the December maturity. The improved free cash flow generation—$35 million in the quarter versus a $2 million outflow a year ago—demonstrates that operating discipline is converting into real cash that can be used to pay down debt further. As the balance sheet continues to strengthen, the company’s cost of capital should decline, supporting higher valuation multiples.
North America’s core portfolio is positioned for a structural margin improvement that exceeds current guidance. Excluding the divested snacks business, adjusted gross margin in North America reached 23.4% in the quarter, with management stating that the go‑forward margin profile would have been 30% excluding snacks and targeting gross margins above 30% and low double‑digit adjusted EBITDA margin post‑divestiture. This outlook is backed by ongoing SKU rationalization, productivity savings, and pricing discipline, which together are driving a more productive assortment and margin stability. The core categories—yogurt, tea, and finger foods—are already showing growth and share gains, indicating that the underlying demand base is resilient. As the company continues to eliminate stranded costs and reinvest margin expansion into innovation and marketing, the North America segment is likely to deliver earnings acceleration that is not fully reflected in today’s consensus estimates. The market may be underestimating the earnings power of a streamlined, higher‑margin North American business.
International segment challenges are showing early signs of reversal, presenting a hidden catalyst that could uplift overall performance. The decline in wet baby food purees has stabilized, with management noting that the industry‑wide slowdown began last May following a BBC documentary and that anniversary effects are expected to drive improvement as the lap period approaches. Ella’s Kitchen, the #1 UK baby and kids brand, has exhibited early consumption improvement in the last two months, and a robust pipeline of finger foods and frozen meals innovation is set to launch, aligned with UK health guidelines. Additionally, Hartley’s brand is undergoing a full relaunch with upgraded fruit content, new flavor combinations, and a 100% fruit spread, supported by premium pricing and in‑store promotions that have already secured expanded distribution for Q1. These initiatives, combined with the anticipated recovery in private label‑competitive soup categories through brand relaunches such as Yorkshire Provender, suggest that the International segment may return to growth sooner than investors anticipate. The market may be discounting the potential for a turnaround in a segment that still represents a significant portion of the company’s sales base.
Operating efficiency initiatives are delivering measurable benefits that are likely to compound over time. Days inventory outstanding improved to 73 days, the lowest in two years, reflecting better inventory management and working capital discipline, while days payable outstanding reached 59 days, indicating improved supplier terms. Capital expenditures have been trimmed to $4 million for the quarter, with a full‑year expectation of approximately $20 million, freeing cash for debt reduction or strategic investments. SG&A expenses fell 6% year‑over‑year to $59 million, and although SG&A as a percentage of net sales rose due to the sales base dilution, the absolute cost base is being tightened through reduced employee‑related expenses and ongoing cost controls. These operational improvements are contributing to stronger free cash flow generation and are creating a foundation for margin expansion as sales stabilize. The market may be undervaluing the cumulative impact of these efficiency gains, which can enhance profitability even without substantial top‑line growth.

The company’s innovation pipeline is a powerful but underappreciated driver of future growth, with more than 12% of net sales now coming from SKUs launched or relaunched within the last three years, up 2.5 points year‑over‑year. This acceleration is supported by concrete product rollouts such as Celestial Seasonings’ wellness tea expansion into gut health and throat support, Earth’s Best Big Kids finger foods, and Greek Gods’ high‑protein single‑serve yogurt, each targeting fast‑growing consumer trends. Management has explicitly linked these innovations to broader distribution gains, repeat purchase behavior, and the ability to command premium pricing, which should translate into sustainable top‑line expansion. The innovation effort is further reinforced by increased marketing effectiveness through digital and social channels, ensuring that new products achieve shelf visibility and consumer trial. As the pipeline continues to mature, the flow‑through benefits to gross margin and operating leverage are likely to exceed current market expectations. Consequently, the stock may be undervaluing the earnings upside from a revitalized product portfolio that can drive both volume recovery and margin expansion.
Debt reduction and balance sheet strengthening provide a tangible catalyst that the market appears to be overlooking. The completed North America Snacks divestiture generated $155 million in debt reduction, cutting net debt to $505 million and improving liquidity to $196 million under the revolver, while leverage stands at a comfortable 4.3x versus a covenant of 5.5x. This deleveraging not only reduces interest expense pressure but also creates flexibility for future strategic moves, such as additional asset sales or reinvestment into high‑growth categories. Management’s commitment to prioritizing net debt reduction over time, coupled with a hedged rate exposure of over 70% at a fixed 7.1%, mitigates refinancing risk ahead of the December maturity. The improved free cash flow generation—$35 million in the quarter versus a $2 million outflow a year ago—demonstrates that operating discipline is converting into real cash that can be used to pay down debt further. As the balance sheet continues to strengthen, the company’s cost of capital should decline, supporting higher valuation multiples.
North America’s core portfolio is positioned for a structural margin improvement that exceeds current guidance. Excluding the divested snacks business, adjusted gross margin in North America reached 23.4% in the quarter, with management stating that the go‑forward margin profile would have been 30% excluding snacks and targeting gross margins above 30% and low double‑digit adjusted EBITDA margin post‑divestiture. This outlook is backed by ongoing SKU rationalization, productivity savings, and pricing discipline, which together are driving a more productive assortment and margin stability. The core categories—yogurt, tea, and finger foods—are already showing growth and share gains, indicating that the underlying demand base is resilient. As the company continues to eliminate stranded costs and reinvest margin expansion into innovation and marketing, the North America segment is likely to deliver earnings acceleration that is not fully reflected in today’s consensus estimates. The market may be underestimating the earnings power of a streamlined, higher‑margin North American business.
International segment challenges are showing early signs of reversal, presenting a hidden catalyst that could uplift overall performance. The decline in wet baby food purees has stabilized, with management noting that the industry‑wide slowdown began last May following a BBC documentary and that anniversary effects are expected to drive improvement as the lap period approaches. Ella’s Kitchen, the #1 UK baby and kids brand, has exhibited early consumption improvement in the last two months, and a robust pipeline of finger foods and frozen meals innovation is set to launch, aligned with UK health guidelines. Additionally, Hartley’s brand is undergoing a full relaunch with upgraded fruit content, new flavor combinations, and a 100% fruit spread, supported by premium pricing and in‑store promotions that have already secured expanded distribution for Q1. These initiatives, combined with the anticipated recovery in private label‑competitive soup categories through brand relaunches such as Yorkshire Provender, suggest that the International segment may return to growth sooner than investors anticipate. The market may be discounting the potential for a turnaround in a segment that still represents a significant portion of the company’s sales base.
Operating efficiency initiatives are delivering measurable benefits that are likely to compound over time. Days inventory outstanding improved to 73 days, the lowest in two years, reflecting better inventory management and working capital discipline, while days payable outstanding reached 59 days, indicating improved supplier terms. Capital expenditures have been trimmed to $4 million for the quarter, with a full‑year expectation of approximately $20 million, freeing cash for debt reduction or strategic investments. SG&A expenses fell 6% year‑over‑year to $59 million, and although SG&A as a percentage of net sales rose due to the sales base dilution, the absolute cost base is being tightened through reduced employee‑related expenses and ongoing cost controls. These operational improvements are contributing to stronger free cash flow generation and are creating a foundation for margin expansion as sales stabilize. The market may be undervaluing the cumulative impact of these efficiency gains, which can enhance profitability even without substantial top‑line growth.

▼ Bear case

The International segment continues to face structural headwinds that could persist beyond the expected lap of the baby food softness, posing a material risk to overall sales. Volume declines in wet baby food, spreads, drizzles, and branded soup remain pronounced, with management acknowledging ongoing challenges in these categories despite early signs of stabilization. The segment’s adjusted gross margin fell 270 basis points to 18.5%, reflecting cost inflation that is not being fully offset by productivity savings or pricing actions, indicating margin pressure that may be difficult to reverse. Private label competition is intensifying, especially in the UK market where consumers are shifting toward cheaper alternatives, and the company’s reliance on branded premium positioning may limit its ability to regain share without substantial investment. While innovation initiatives such as Hartley’s relaunch and Ella’s Kitchen frozen meals are underway, their success hinges on execution, retail acceptance, and consumer adoption, which remain uncertain. If these efforts fail to generate meaningful sales uplift, the International segment could continue to drag down consolidated profitability, a risk that the market may be underestimating given the current focus on North America improvements.
Interest expense remains a notable burden that could constrain financial flexibility despite recent debt reduction. Interest expense rose 17% year‑over‑year to $14 million, driven by higher spreads over variable rates from last year’s refinancing and increased amortization of deferred financing fees, highlighting that the company’s debt structure still carries a significant cost. Although over 70% of the loan facility is hedged at a fixed 7.1%, the remaining unhedged portion exposes the company to potential rate increases, and the overall leverage of 4.3x, while below covenant limits, still leaves limited headroom for adverse earnings shocks. The company’s commitment to prioritizing net debt reduction may limit its ability to invest aggressively in growth initiatives, as cash flow is directed toward debt service. Should operating performance falter, the interest coverage ratio could deteriorate quickly, raising concerns about covenant compliance and refinancing risk at the December maturity. The market may be overlooking the persistent drag that interest costs place on earnings and cash flow availability.
Stranded costs, while being addressed, still represent a lingering expense that could impede margin improvement if not fully eliminated. Management expects stranded costs to be in the high end of the $20 million to $25 million range, with nearly 70% already removed, primarily people‑related, but the remainder targeted for elimination by fiscal 2027. This means that a meaningful portion of these costs will continue to affect the income statement for the next two years, potentially offsetting gains from gross margin improvement and SG&A reductions. The timing of cost removal is uncertain, and any delay in executing the remaining cost‑saving actions could prolong the drag on profitability. Furthermore, the reliance on people‑related cost reductions may raise concerns about workforce morale and operational effectiveness, potentially impacting innovation execution and customer service. If stranded costs persist longer than anticipated, the company’s adjusted EBITDA margin improvement may be slower than projected, a risk that is not fully captured in current bullish outlooks.
The company’s growth assumptions are heavily contingent on the successful execution of its innovation pipeline, which carries inherent execution risk. While innovation contributed 12% of net sales in the quarter, translating early share gains into sustained, category‑defining growth requires consistent marketing investment, retail support, and consumer acceptance over a multi‑year horizon. Management acknowledges that innovation must be leveraged over a three‑year time horizon to stick, yet the current quarter’s marketing investment increase in North America and the planned acceleration internationally may not be sufficient if competitive responses intensify or if consumer preferences shift unexpectedly. Moreover, the pipeline’s focus on premium, better‑for‑you offerings may limit appeal in price‑sensitive segments, especially amid macroeconomic uncertainty that could drive consumers toward value‑oriented private label products. Should innovation fail to deliver the expected lift in volume and pricing power, the company’s revenue growth could remain stagnant or decline, undermining the bullish thesis built around product renewal.
Macroeconomic and competitive pressures could erode the stability of the North America core categories that are currently driving growth. Although management reports stable promotional activity and limited competitive upswing in yogurt, tea, and finger foods, the broader environment remains uncertain, with potential for increased trade spend from rivals seeking to gain share in a sluggish market. Any uptick in competitor discounting or promotional aggressiveness could force Hain to increase its own marketing and trade spending to defend share, pressuring margins despite the company’s intention to be surgical with spend. Additionally, the company’s reliance on a limited set of core brands for growth means that any setback in those categories—such as a supply chain disruption, a shift in consumer taste away from Greek yogurt or herbal tea, or a regulatory challenge—could have an outsized impact on overall performance. The market may be underestimating the vulnerability of a turnaround strategy that leans heavily on a few bright spots within a otherwise challenged portfolio.

The International segment continues to face structural headwinds that could persist beyond the expected lap of the baby food softness, posing a material risk to overall sales. Volume declines in wet baby food, spreads, drizzles, and branded soup remain pronounced, with management acknowledging ongoing challenges in these categories despite early signs of stabilization. The segment’s adjusted gross margin fell 270 basis points to 18.5%, reflecting cost inflation that is not being fully offset by productivity savings or pricing actions, indicating margin pressure that may be difficult to reverse. Private label competition is intensifying, especially in the UK market where consumers are shifting toward cheaper alternatives, and the company’s reliance on branded premium positioning may limit its ability to regain share without substantial investment. While innovation initiatives such as Hartley’s relaunch and Ella’s Kitchen frozen meals are underway, their success hinges on execution, retail acceptance, and consumer adoption, which remain uncertain. If these efforts fail to generate meaningful sales uplift, the International segment could continue to drag down consolidated profitability, a risk that the market may be underestimating given the current focus on North America improvements.
Interest expense remains a notable burden that could constrain financial flexibility despite recent debt reduction. Interest expense rose 17% year‑over‑year to $14 million, driven by higher spreads over variable rates from last year’s refinancing and increased amortization of deferred financing fees, highlighting that the company’s debt structure still carries a significant cost. Although over 70% of the loan facility is hedged at a fixed 7.1%, the remaining unhedged portion exposes the company to potential rate increases, and the overall leverage of 4.3x, while below covenant limits, still leaves limited headroom for adverse earnings shocks. The company’s commitment to prioritizing net debt reduction may limit its ability to invest aggressively in growth initiatives, as cash flow is directed toward debt service. Should operating performance falter, the interest coverage ratio could deteriorate quickly, raising concerns about covenant compliance and refinancing risk at the December maturity. The market may be overlooking the persistent drag that interest costs place on earnings and cash flow availability.
Stranded costs, while being addressed, still represent a lingering expense that could impede margin improvement if not fully eliminated. Management expects stranded costs to be in the high end of the $20 million to $25 million range, with nearly 70% already removed, primarily people‑related, but the remainder targeted for elimination by fiscal 2027. This means that a meaningful portion of these costs will continue to affect the income statement for the next two years, potentially offsetting gains from gross margin improvement and SG&A reductions. The timing of cost removal is uncertain, and any delay in executing the remaining cost‑saving actions could prolong the drag on profitability. Furthermore, the reliance on people‑related cost reductions may raise concerns about workforce morale and operational effectiveness, potentially impacting innovation execution and customer service. If stranded costs persist longer than anticipated, the company’s adjusted EBITDA margin improvement may be slower than projected, a risk that is not fully captured in current bullish outlooks.
The company’s growth assumptions are heavily contingent on the successful execution of its innovation pipeline, which carries inherent execution risk. While innovation contributed 12% of net sales in the quarter, translating early share gains into sustained, category‑defining growth requires consistent marketing investment, retail support, and consumer acceptance over a multi‑year horizon. Management acknowledges that innovation must be leveraged over a three‑year time horizon to stick, yet the current quarter’s marketing investment increase in North America and the planned acceleration internationally may not be sufficient if competitive responses intensify or if consumer preferences shift unexpectedly. Moreover, the pipeline’s focus on premium, better‑for‑you offerings may limit appeal in price‑sensitive segments, especially amid macroeconomic uncertainty that could drive consumers toward value‑oriented private label products. Should innovation fail to deliver the expected lift in volume and pricing power, the company’s revenue growth could remain stagnant or decline, undermining the bullish thesis built around product renewal.
Macroeconomic and competitive pressures could erode the stability of the North America core categories that are currently driving growth. Although management reports stable promotional activity and limited competitive upswing in yogurt, tea, and finger foods, the broader environment remains uncertain, with potential for increased trade spend from rivals seeking to gain share in a sluggish market. Any uptick in competitor discounting or promotional aggressiveness could force Hain to increase its own marketing and trade spending to defend share, pressuring margins despite the company’s intention to be surgical with spend. Additionally, the company’s reliance on a limited set of core brands for growth means that any setback in those categories—such as a supply chain disruption, a shift in consumer taste away from Greek yogurt or herbal tea, or a regulatory challenge—could have an outsized impact on overall performance. The market may be underestimating the vulnerability of a turnaround strategy that leans heavily on a few bright spots within a otherwise challenged portfolio.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Packaged Foods

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	KHC	Kraft Heinz Co	30.29 Bn	-5.26	1.21	21.13 Bn
2	GIS	General Mills Inc	19.35 Bn	-2,199.07	1.05	13.47 Bn
3	HRL	Hormel Foods Corp /De/	13.90 Bn	29.79	1.14	2.86 Bn
4	MKC	Mccormick & Co Inc	13.45 Bn	18.95	1.82	3.61 Bn
5	MICC	Magnum Ice Cream Co N.V.	10.95 Bn	31.87	1.18	3.85 Bn
6	SFD	Smithfield Foods Inc	10.34 Bn	41.19	0.66	2.00 Bn
7	DAR	Darling Ingredients Inc.	9.92 Bn	57.52	1.66	4.13 Bn
8	OTLY	Oatly Group AB	8.23 Bn	-54.03	9.21	0.00 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password